Update on worldwide efforts to prevent type 1 diabetes

Research output: Chapter in Book/Report/Conference proceedingConference contribution

44 Scopus citations

Abstract

This paper reviews worldwide efforts to interdict the type 1 diabetes (T1D) disease process, during the stage of evolution of the disease prior to the time of disease onset. The goal of intervention before disease onset is to arrest immune destruction and thus prevent or delay clinical disease. In this regard, there have been several large-scale multicenter randomized controlled clinical trials designed to prevent T1D. These have tested nicotinamide, parenteral insulin, oral insulin, nasal insulin, and the elimination of cow's milk from infant feeding.

Original languageEnglish (US)
Title of host publicationImmunology of Diabetes V From Bench to Bedside
PublisherBlackwell Publishing Inc.
Pages190-196
Number of pages7
ISBN (Print)9781573317337
DOIs
StatePublished - Dec 2008

Publication series

NameAnnals of the New York Academy of Sciences
Volume1150
ISSN (Print)0077-8923
ISSN (Electronic)1749-6632

Keywords

  • Clinical trials
  • Immunomodulation
  • Prevention
  • Type 1 diabetes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Update on worldwide efforts to prevent type 1 diabetes'. Together they form a unique fingerprint.

  • Cite this

    Skyler, J. S. (2008). Update on worldwide efforts to prevent type 1 diabetes. In Immunology of Diabetes V From Bench to Bedside (pp. 190-196). (Annals of the New York Academy of Sciences; Vol. 1150). Blackwell Publishing Inc.. https://doi.org/10.1196/annals.1447.055